CD274 and breast cancer: Because of this, higher overall long-term outcomes with immunotherapy can be attained in inflamed cancer types [6, 7], whereas in non-inflamed cancer types, such as a large proportion of luminal B BC, results with isolated PD-1/PD-L1 blockade are disappointing.